Appraisal of Paclitaxel Pros and Cons in Cancer Management and Drug Repurposing Prospects

    January 2023 in “ IntechOpen eBooks
    John Oluwafemi Teibo, Chioma Ejiro Irozuru, Titilade Kehinde Ayandeyi Teibo, Olabode Omotoso, Ahmad O. Babalghith, Gaber El‐Saber Batiha
    TLDR Paclitaxel is an effective cancer drug with side effects and potential new uses beyond cancer.
    Paclitaxel (Taxol) is a potent anticancer drug effective against various cancers, including breast and ovarian cancer, by obstructing mitotic spindle formation and arresting the cell cycle at the G2/M phase. Despite its efficacy, it has notable side effects such as hair loss, numbness, and bone marrow suppression, and faces resistance mechanisms like P-glycoprotein efflux pumps. Combining paclitaxel with cisplatin improves survival rates in breast cancer patients. Recent studies suggest its potential in treating non-cancer diseases like COVID-19 and fibrosis. Future advancements may enhance its biosynthesis, reduce chemo-resistance, and improve targeted delivery, potentially expanding its therapeutic uses.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 1000+ results

    Similar Research

    5 / 1000+ results
      Red Ginseng Monograph

      research Red Ginseng Monograph

      67 citations, May 2018 in “Journal of Ginseng Research”
      Red ginseng may improve immunity, fatigue, memory, blood circulation, and menopausal symptoms, and is generally safe to consume.

      research Pharmacological Activity Of Cepharanthine

      3 citations, June 2023 in “Molecules/Molecules online/Molecules annual”
      Cepharanthine has many medicinal uses but needs improvement for better effectiveness.
      Men's Health

      research Men's Health

      February 1999 in “Drugs in R & D”
      The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.